NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The Company offers services, such as Mitochondrial Replacement Therapy In Reproductive, Intrauterine Insemination (IUI), Mitochondrial replacement therapy (MRT) techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular / epididymal sperm aspiration or extraction / percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening and egg freezing. The Companyâs clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. MRT involves an additional egg from a third person, and manipulating both the recipient egg and the donor egg.
äŒæ¥ã³ãŒãNIVFW
äŒç€ŸåNewGenIvf Group Ltd
äžå Žæ¥Feb 15, 2022
æé«çµå¶è²¬ä»»è
ãCEOãMr. Siu (Alfred) Wing Fung
åŸæ¥å¡æ°- -
蚌åžçš®é¡Company Warrant
æ±ºç®ææ«- -
æ¬ç€Ÿæåšå°Level 39, Marina Bay Financial Centre
éœåž
蚌åžååŒæNASDAQ Capital Market Consolidated
åœSingapore
éµäŸ¿çªå·018983
é»è©±çªå·6568185796
ãŠã§ããµã€ãhttps://newgenivf.com/
äŒæ¥ã³ãŒãNIVFW
äžå Žæ¥Feb 15, 2022
æé«çµå¶è²¬ä»»è
ãCEOãMr. Siu (Alfred) Wing Fung
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã